Blood News and Research

RSS

Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Researchers at the Yerkes National Primate Research Center, Emory University, have shown inducing the release of brain oxytocin may be a viable therapeutic option for enhancing social function in psychiatric disorders, including autism spectrum disorders and schizophrenia.

4 Mar 2015

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Bayer HealthCare today announced that the U.S. Food and Drug Administration has accepted the company's Biologics License Application for BAY 81-8973, a recombinant Factor VIII compound. Bayer is seeking FDA approval of the investigational compound, proposed trade name Kovaltry, for the treatment of hemophilia A in children and adults.

4 Mar 2015

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

The main types of NCD are cardiovascular disease, cancer, chronic respiratory diseases and diabetes. These have been identified as the principal conditions for three main reasons. One is that, collectively, they contribute the most to the total disease burden.

4 Mar 2015

Study shows strong link between adolescent obesity and high blood pressure

A recent study published in the American Journal of Hypertension has found that body mass index (BMI) in healthy adolescents has a statistically significant association with both systolic blood pressures (SBP) and diastolic blood pressures (DBP), and highlights the significance of the global trend of rapidly increasing adolescent obesity.

4 Mar 2015

Researchers find new retrovirus 'fossil' in vampire bats

Scientists discovered a new retrovirus "fossil" found in the common vampire bat which is homologous to retroviruses in rodents and primates. The results suggest the recent circulation of an active infectious retrovirus and cross-species transmission.

4 Mar 2015

$New guidance to prevent bisphosphonate-related atypical femoral fractures$

New guidance to prevent bisphosphonate-related atypical femoral fractures

Physicians worldwide frequently prescribe bisphosphonates such as alendronate (Fosamax) and ibandronate (Boniva) to treat osteoporosis and prevent fragility fractures. Unfortunately, long-term bisphosphonate use has been linked to an increased risk of atypical femoral fractures.

4 Mar 2015

CCO wants men and women in Ontario to get screened for colorectal cancer

March is Colorectal Cancer Awareness Month, and Cancer Care Ontario wants men and women to start thinking about getting screened.

4 Mar 2015

Novogen's TRXE-009 therapy shows promise against brain cancer

Australian/US biotechnology company, Novogen Limited, today announces that it has confirmed that one of its lead candidate products, TRXE-009, is showing the potential to become an important new therapy in the fight against adult and pediatric brain cancer.

4 Mar 2015

Study explores outcomes of lung transplantations after implementing need-based allocation system

Since implementation of a medical need-based allocation system of donor lungs in 2005, double-lung transplantation has been associated with better graft survival than single-lung transplantation in patients with idiopathic pulmonary fibrosis (IPF); at 5 years, there has been no survival difference between single- and double-lung transplant recipients in patients with chronic obstructive pulmonary disease (COPD), according to a study in the March 3 issue of JAMA.

4 Mar 2015

Grifols, Alkahest sign definitive agreements

Grifols, a global healthcare company and leading producer of plasma therapies, and Alkahest, a Redwood City, California based, privately held biopharmaceutical company founded upon the pioneering work of Dr. Tony Wyss-Coray and other leading scientists at Stanford University, today announced that they have signed definitive agreements whereby Grifols will make a major equity investment in Alkahest, and the companies will work together to develop novel plasma-based products for the treatment of cognitive decline in aging and disorders of the central nervous system (CNS), including Alzheimer's.

4 Mar 2015

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

SARAH, a large French study of patients with advanced, inoperable primary liver cancer (hepatocellular carcinoma, or HCC) has completed patient enrolment, exceeding its 400-patient target, according to its principal investigator, Professor Valérie Vilgrain MD, PhD, Department of Radiology, Beaujon Hospital, Assistance Publique - Hôpitaux de Paris (AP-HP) and Université Paris Diderot, Sorbonne Paris Cité, France.

4 Mar 2015

UF researchers find that people with brain tumor fare better with personal insurance

Brain tumor patients who are uninsured or use Medicaid stay hospitalized longer and develop more medical complications than those with private insurance, University of Florida Health researchers have found.

4 Mar 2015

New study shows who benefits most from statin therapy

Research has demonstrated that the risk for developing coronary heart disease depends on a host of risk factors that are related both to lifestyle and genetics. In a new study from Brigham and Women's Hospital, Washington University School of Medicine in St. Louis, and Massachusetts General Hospital, researchers tested whether a composite of genetic variants could identify the risk of cardiovascular death and heart attacks as well as identify individuals who derived greater clinical benefit from statin therapy.

4 Mar 2015

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Over the last century, life expectancy for Spaniards has increased by 40 years. A study by the International University of La Rioja highlights the main cause, since 1980, as being the reduced incidence of cardiovascular diseases while other pathologies, such as mental illnesses and certain types of cancer, have been seen to rise. The authors predict that the effects of the economic recession on mortality will show up in the long-term.

4 Mar 2015

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

A blood test yields a wealth of information crucial to a person's health. What's needed is a device that is small and inexpensive, yet capable of quickly providing a thorough analysis using a very small sample.

4 Mar 2015

Novel drug mechanism shows promise against glioma cells

Researchers at UC Davis have developed and characterized a molecule that interferes with the internal regulation of cancer cells, causing them to self-destruct. This novel mechanism was found to be effective against glioma cells - responsible for a usually fatal type of brain cancer - and could be applicable to other highly aggressive cancers.

4 Mar 2015

Key questions about colorectal cancer answered

Colorectal cancer is the fourth most common cancer in the U.S., with more than 136,000 new patients diagnosed last year. But thanks to increased awareness about screenings, the death rate from colorectal cancer has been dropping for more than 20 years.

4 Mar 2015

Blood News and Research

Oxytocin may be a potential therapeutic target for improving social function in psychiatric disorders

Bayer announces FDA acceptance of BAY 81-8973 BLA for treatment of hemophilia A

Reducing premature deaths from noncommunicable diseases: an interview with Dr Shanthi Mendis, WHO

Study shows strong link between adolescent obesity and high blood pressure

Researchers find new retrovirus 'fossil' in vampire bats

New guidance to prevent bisphosphonate-related atypical femoral fractures

CCO wants men and women in Ontario to get screened for colorectal cancer

Novogen's TRXE-009 therapy shows promise against brain cancer

Study explores outcomes of lung transplantations after implementing need-based allocation system

Grifols, Alkahest sign definitive agreements

SARAH study completes patient enrolment to evaluate treatment for primary liver cancer

UF researchers find that people with brain tumor fare better with personal insurance

New study shows who benefits most from statin therapy

Life expectancy for Spaniards increases due to 'cardiovascular revolution'

Apollo signs license option deal with Case Western to develop point-of-care blood analyzer

Novel drug mechanism shows promise against glioma cells

Key questions about colorectal cancer answered

Salt may help control infection

UCLA life scientists develop new method to find genetic markers for many diseases

Direct effects of stress increases mortality, ill-health among unemployed people

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News